Azedra Approved for Rare Adrenal Tumors

TUESDAY, July 31, 2018 — Azedra (iobenguane) has been approved by the U.S. Food and Drug Administration to treat people 12 and older with rare adrenal gland tumors that can’t be surgically removed and have spread beyond the original site.
The…
Source: Topamax